via Phys.org
Researchers at the University of Gothenburg in Sweden, together with their colleagues at the Barcelona Beta Research Centre in Spain, the University Medical Centre in Ljubljana, Slovenia, and the University of Paris, have found new forms of tau protein that become abnormal in the very early stages of Alzheimer’s disease before cognitive problems develop. The scientists developed new tools to detect these subtle changes and confirmed their results in human samples
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Alzheimer’s disease
- Experts list anti-inflammation foods that reduce risk of cancer and dementia
Harvard Health experts have prescribed a menu of anti-inflammatory foods that could significantly reduce your odds of developing cancer, diabetes and dementia ... and you could accelerate the ...
- Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
Researchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic processes behind Alzheimer's disease, leading to potential new strategies for treatment. Alzheimer's ...
- Cancer breakthrough as 2p dementia pill could help stave off disease, research shows
Research conducted in France found that individuals exhibiting vitamin D levels below 50 nmol/L were nearly three times more likely to develop Alzheimer's disease. The researchers were surprised to ...
- Commentary: As Alzheimer’s risk grows, caregivers need support
According to a new report from the Florida Chapters of the Alzheimer’s Association, an estimated one in eight people are living with Alzheimer’s. More than 840,000 are serving as their unpaid ...
- Study says these three diets reduce Alzheimer's disease
New research showed people's diet and other activities that challenge the brain may help fight off Alzheimer's disease.
Go deeper with Google Headlines on:
Alzheimer’s disease
[google_news title=”” keyword=”Alzheimer’s disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
P-tau markers
- Biomarkers Market Worth $93.8 billion | MarketsandMarkets
The agreement grants Quanterix non-exclusive rights to J&J's p-Tau 217 antibodies and assay designs, enabling the development of a potential Laboratory Developed Test (LDT) for Alzheimer's Disease (AD ...
- Biomarkers Market Worth $93.8 billion | MarketsandMarkets™
Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing ...
- Dozens arrested at NYU as pro-Palestinian encampments spread across city and beyond
Around 8:35 p.m. Monday, dozens of police officers in riot gear went on campus and started detaining protesters.
- INmune Bio: An Opportunity In The Freefall (Rating Upgrade)
INmune Bio is focused on developing drugs for neurology and cancer medicine. Find out why INMB stock is a Buy.
- Could New Alzheimer’s Marker p-Tau212 Rival p-Tau217?
Among plasma biomarkers for Alzheimer’s disease, p-Tau217 stands tall as having the highest diagnostic accuracy. Now, in the March 23 Nature Communications, researchers led by Przemyslaw Kac, Thomas ...
Go deeper with Google Headlines on:
P-tau markers
[google_news title=”” keyword=”p-tau markers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]